Dry Eye Syndrome Market Epidemiology Report for 9 Major Regions

PUNE, India, November 25, 2015 /PRNewswire/ --

EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2024 is a market research that provides an overview of the risk factors, comorbidities, and global trends for DES in the nine major markets (9MM) (US, France, Germany, Italy, Spain, UK, Japan, China, and India). It includes a 10-year epidemiological forecast of the total prevalent cases of DES segmented by sex, age, and severity in these markets.

Complete report on Dry Eye Syndrome - Epidemiology Forecast to 2024 spread across 41 pages, supported with 6 tables and 4 figures is now available at http://www.reportsnreports.com/reports/442035-epicast-report-dry-eye-syndrome-epidemiology-forecast-to-2024.html .

Epidemiologists forecast an increase in the total prevalent cases of DES in the 9MM, from 414,273,756 total prevalent cases in 2014 to 460,865,914 total prevalent cases in 2024, with an Annual Growth Rate (AGR) of 1.12% during the forecast period.

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. It results in symptoms of discomfort such as visual disturbance and tear film instability. Middle-aged and older adults are the most commonly affected group because of the high prevalence of contact lens usage, systemic drug effects, autoimmune diseases, and refractive surgeries in these groups.

Order a copy of EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2024 market research report at http://www.reportsnreports.com/purchase.aspx?name=442035 .

This report provides an overview of the risk factors, comorbidities, as well as the global and historical epidemiological trends for DES in the nine major markets. The report also includes a 10-year epidemiology forecast for the total prevalent cases of dry eye syndrome, segmented by age (in 10-year increments beginning at ages 20 years and ending at ages =80 years), sex, and severity in these markets. The epidemiology forecast for DES is supported by historical data obtained from peer-reviewed articles, government reports, and population-based studies. The researchers of the study used questionnaires to assess DES symptoms, along with various diagnostic tests such as aqueous tear flow, ocular surface damage, and measurements of tear film instability for the 9MM in this analysis. The forecast methodology was kept consistent across all the markets to allow for a meaningful comparison of the forecast total prevalent cases of DES across these markets.

Another newly published market research titled Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H2 2015 provides comprehensive information on the therapeutic development for Keratoconjunctivitis sicca (Dry Eye), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keratoconjunctivitis sicca (Dry Eye) and special features on late-stage and discontinued projects. The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities and key players involved in the therapeutics development for Keratoconjunctivitis sicca (Dry Eye) and enlists all their major and minor projects. Read more at http://www.reportsnreports.com/reports/432807-keratoconjunctivitis-sicca-dry-eye-pipeline-review-h2-2015.html .

Explore more reports on Pharmaceuticals industry at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us:   

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com